Concepts (222)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cornea | 31 | 2023 | 55 | 4.280 |
Why?
|
| Keratoconus | 15 | 2023 | 15 | 3.190 |
Why?
|
| Myopia | 14 | 2023 | 26 | 2.700 |
Why?
|
| Refractive Errors | 13 | 2022 | 25 | 2.530 |
Why?
|
| Visual Acuity | 21 | 2023 | 98 | 2.350 |
Why?
|
| Down Syndrome | 9 | 2022 | 29 | 2.340 |
Why?
|
| Corneal Topography | 24 | 2023 | 24 | 2.300 |
Why?
|
| Vision Screening | 6 | 2022 | 21 | 1.930 |
Why?
|
| Vision Disorders | 5 | 2020 | 59 | 1.400 |
Why?
|
| Anterior Chamber | 5 | 2020 | 11 | 1.320 |
Why?
|
| Lasers, Excimer | 6 | 2023 | 7 | 1.290 |
Why?
|
| Photorefractive Keratectomy | 5 | 2023 | 6 | 1.270 |
Why?
|
| Refraction, Ocular | 17 | 2023 | 28 | 1.230 |
Why?
|
| Photochemotherapy | 6 | 2023 | 37 | 1.070 |
Why?
|
| Lens Implantation, Intraocular | 3 | 2015 | 6 | 1.030 |
Why?
|
| Phacoemulsification | 3 | 2015 | 8 | 1.020 |
Why?
|
| Astigmatism | 6 | 2021 | 7 | 1.010 |
Why?
|
| Iran | 26 | 2022 | 183 | 0.990 |
Why?
|
| Cross-Linking Reagents | 7 | 2023 | 48 | 0.930 |
Why?
|
| Humans | 75 | 2023 | 34853 | 0.810 |
Why?
|
| Universities | 2 | 2020 | 363 | 0.780 |
Why?
|
| Evaluation Studies as Topic | 1 | 2020 | 51 | 0.780 |
Why?
|
| Keratomileusis, Laser In Situ | 3 | 2023 | 4 | 0.770 |
Why?
|
| Academies and Institutes | 1 | 2020 | 35 | 0.770 |
Why?
|
| Eyeglasses | 3 | 2016 | 21 | 0.760 |
Why?
|
| Riboflavin | 6 | 2022 | 24 | 0.760 |
Why?
|
| Mitomycin | 3 | 2015 | 11 | 0.730 |
Why?
|
| Alkylating Agents | 3 | 2015 | 13 | 0.730 |
Why?
|
| Female | 55 | 2023 | 19873 | 0.730 |
Why?
|
| Male | 52 | 2022 | 18870 | 0.730 |
Why?
|
| Prospective Studies | 17 | 2022 | 1353 | 0.720 |
Why?
|
| Adult | 44 | 2023 | 11034 | 0.720 |
Why?
|
| Hyperopia | 5 | 2019 | 7 | 0.660 |
Why?
|
| Amblyopia | 4 | 2019 | 13 | 0.610 |
Why?
|
| Minority Groups | 2 | 2023 | 537 | 0.590 |
Why?
|
| Patient Education as Topic | 1 | 2018 | 207 | 0.590 |
Why?
|
| Schools | 1 | 2018 | 229 | 0.590 |
Why?
|
| Tears | 2 | 2014 | 11 | 0.590 |
Why?
|
| Endothelium, Corneal | 3 | 2020 | 5 | 0.570 |
Why?
|
| Aniridia | 1 | 2015 | 2 | 0.560 |
Why?
|
| Albinism, Oculocutaneous | 1 | 2015 | 5 | 0.560 |
Why?
|
| Prosthesis Implantation | 1 | 2015 | 13 | 0.560 |
Why?
|
| Prostheses and Implants | 1 | 2015 | 14 | 0.560 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 5 | 2017 | 15 | 0.550 |
Why?
|
| Young Adult | 22 | 2021 | 4012 | 0.550 |
Why?
|
| Photosensitizing Agents | 7 | 2023 | 47 | 0.540 |
Why?
|
| Middle Aged | 32 | 2021 | 9642 | 0.520 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2018 | 375 | 0.500 |
Why?
|
| Pseudophakia | 2 | 2012 | 2 | 0.500 |
Why?
|
| Child | 15 | 2022 | 2875 | 0.490 |
Why?
|
| Refractometry | 1 | 2014 | 14 | 0.490 |
Why?
|
| Aging | 8 | 2022 | 639 | 0.480 |
Why?
|
| Photography | 3 | 2011 | 46 | 0.470 |
Why?
|
| Delivery of Health Care | 1 | 2016 | 254 | 0.460 |
Why?
|
| Adolescent | 21 | 2021 | 5035 | 0.460 |
Why?
|
| Cross-Sectional Studies | 20 | 2020 | 2561 | 0.440 |
Why?
|
| Cataract Extraction | 4 | 2015 | 16 | 0.410 |
Why?
|
| Child, Preschool | 7 | 2022 | 1318 | 0.390 |
Why?
|
| Collagen | 4 | 2022 | 162 | 0.390 |
Why?
|
| Lenses, Intraocular | 1 | 2010 | 4 | 0.380 |
Why?
|
| Pupil | 3 | 2020 | 9 | 0.370 |
Why?
|
| Descemet Membrane | 1 | 2009 | 1 | 0.350 |
Why?
|
| Corneal Transplantation | 1 | 2009 | 2 | 0.350 |
Why?
|
| Follow-Up Studies | 9 | 2022 | 964 | 0.350 |
Why?
|
| Intraoperative Complications | 1 | 2009 | 18 | 0.350 |
Why?
|
| Prevalence | 11 | 2022 | 1425 | 0.330 |
Why?
|
| Contrast Sensitivity | 4 | 2018 | 31 | 0.320 |
Why?
|
| Corneal Surgery, Laser | 1 | 2007 | 1 | 0.320 |
Why?
|
| Aged | 13 | 2019 | 6448 | 0.310 |
Why?
|
| Retrospective Studies | 7 | 2019 | 1961 | 0.310 |
Why?
|
| Biomedical Research | 2 | 2023 | 371 | 0.300 |
Why?
|
| Students | 2 | 2023 | 452 | 0.300 |
Why?
|
| Reproducibility of Results | 7 | 2016 | 901 | 0.300 |
Why?
|
| Strabismus | 2 | 2016 | 17 | 0.280 |
Why?
|
| Postoperative Period | 4 | 2015 | 26 | 0.280 |
Why?
|
| Retinoscopy | 4 | 2021 | 11 | 0.280 |
Why?
|
| Reference Values | 6 | 2020 | 204 | 0.260 |
Why?
|
| Anisometropia | 2 | 2021 | 4 | 0.260 |
Why?
|
| Los Angeles | 4 | 2022 | 368 | 0.250 |
Why?
|
| Dry Eye Syndromes | 2 | 2014 | 5 | 0.240 |
Why?
|
| Age Distribution | 7 | 2016 | 223 | 0.240 |
Why?
|
| Light | 2 | 2018 | 180 | 0.240 |
Why?
|
| Intraocular Pressure | 3 | 2020 | 121 | 0.240 |
Why?
|
| Corneal Dystrophy, Juvenile Epithelial of Meesmann | 1 | 2023 | 1 | 0.230 |
Why?
|
| Incidence | 4 | 2019 | 882 | 0.230 |
Why?
|
| Nomograms | 1 | 2022 | 11 | 0.230 |
Why?
|
| Glare | 3 | 2017 | 4 | 0.210 |
Why?
|
| Health Status Disparities | 2 | 2022 | 583 | 0.210 |
Why?
|
| Cohort Studies | 7 | 2022 | 1422 | 0.210 |
Why?
|
| Vaccines | 1 | 2022 | 49 | 0.210 |
Why?
|
| Aged, 80 and over | 6 | 2016 | 2333 | 0.200 |
Why?
|
| Sex Distribution | 5 | 2016 | 212 | 0.200 |
Why?
|
| Benchmarking | 1 | 2020 | 27 | 0.200 |
Why?
|
| Corneal Endothelial Cell Loss | 1 | 2020 | 1 | 0.190 |
Why?
|
| Government Programs | 1 | 2020 | 28 | 0.190 |
Why?
|
| Basic Reproduction Number | 1 | 2020 | 2 | 0.190 |
Why?
|
| Corneal Stroma | 3 | 2018 | 6 | 0.190 |
Why?
|
| Leadership | 1 | 2020 | 63 | 0.190 |
Why?
|
| Health Services Needs and Demand | 3 | 2016 | 143 | 0.180 |
Why?
|
| Eye Diseases | 1 | 2019 | 23 | 0.180 |
Why?
|
| Mothers | 1 | 2021 | 164 | 0.180 |
Why?
|
| Cultural Diversity | 1 | 2020 | 158 | 0.180 |
Why?
|
| Tonometry, Ocular | 2 | 2016 | 30 | 0.170 |
Why?
|
| Physician's Role | 1 | 2019 | 34 | 0.170 |
Why?
|
| Polypharmacy | 1 | 2019 | 27 | 0.170 |
Why?
|
| Night Vision | 1 | 2018 | 3 | 0.170 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 63 | 0.170 |
Why?
|
| Color Vision | 1 | 2018 | 7 | 0.170 |
Why?
|
| Ultraviolet Rays | 4 | 2022 | 116 | 0.170 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 70 | 0.170 |
Why?
|
| Elasticity | 2 | 2017 | 38 | 0.170 |
Why?
|
| Anterior Eye Segment | 2 | 2019 | 12 | 0.160 |
Why?
|
| Population Surveillance | 1 | 2019 | 231 | 0.160 |
Why?
|
| Time Factors | 6 | 2019 | 1681 | 0.160 |
Why?
|
| Diabetes Complications | 1 | 2018 | 91 | 0.160 |
Why?
|
| Ultrasonics | 2 | 2007 | 12 | 0.160 |
Why?
|
| Self Medication | 1 | 2017 | 13 | 0.160 |
Why?
|
| Healthcare Disparities | 1 | 2022 | 446 | 0.150 |
Why?
|
| Blindness | 1 | 2016 | 16 | 0.150 |
Why?
|
| Vision, Low | 1 | 2016 | 13 | 0.150 |
Why?
|
| Public Health | 1 | 2021 | 348 | 0.150 |
Why?
|
| Convergence, Ocular | 1 | 2016 | 3 | 0.150 |
Why?
|
| Combined Modality Therapy | 2 | 2015 | 142 | 0.150 |
Why?
|
| Cataract | 3 | 2015 | 26 | 0.150 |
Why?
|
| Physical Examination | 1 | 2016 | 40 | 0.140 |
Why?
|
| Eye Movements | 1 | 2015 | 13 | 0.140 |
Why?
|
| Ophthalmology | 1 | 2016 | 28 | 0.140 |
Why?
|
| Academic Medical Centers | 1 | 2016 | 54 | 0.140 |
Why?
|
| Caregivers | 1 | 2017 | 167 | 0.130 |
Why?
|
| Socioeconomic Factors | 2 | 2017 | 1003 | 0.130 |
Why?
|
| Debridement | 1 | 2014 | 4 | 0.130 |
Why?
|
| Elastic Tissue | 1 | 2014 | 7 | 0.130 |
Why?
|
| Color Vision Defects | 1 | 2014 | 2 | 0.120 |
Why?
|
| Solvents | 1 | 2014 | 93 | 0.120 |
Why?
|
| United States | 3 | 2020 | 3894 | 0.120 |
Why?
|
| Body Weights and Measures | 3 | 2009 | 23 | 0.120 |
Why?
|
| National Eye Institute (U.S.) | 1 | 2013 | 3 | 0.120 |
Why?
|
| Sickness Impact Profile | 1 | 2013 | 20 | 0.120 |
Why?
|
| Fluorophotometry | 1 | 2013 | 1 | 0.120 |
Why?
|
| Statistical Distributions | 1 | 2013 | 3 | 0.120 |
Why?
|
| Treatment Outcome | 4 | 2023 | 1349 | 0.120 |
Why?
|
| Diabetes Mellitus | 1 | 2018 | 465 | 0.110 |
Why?
|
| Conflict of Interest | 1 | 2012 | 10 | 0.110 |
Why?
|
| Ultrasonography | 2 | 2011 | 115 | 0.110 |
Why?
|
| Editorial Policies | 1 | 2012 | 13 | 0.110 |
Why?
|
| Bibliometrics | 1 | 2012 | 16 | 0.110 |
Why?
|
| Presbyopia | 1 | 2012 | 1 | 0.110 |
Why?
|
| Postoperative Care | 1 | 2012 | 18 | 0.110 |
Why?
|
| Disclosure | 1 | 2012 | 31 | 0.110 |
Why?
|
| Ethanol | 1 | 2014 | 188 | 0.110 |
Why?
|
| Double-Blind Method | 1 | 2013 | 269 | 0.110 |
Why?
|
| Glaucoma | 1 | 2013 | 87 | 0.110 |
Why?
|
| Periodicals as Topic | 1 | 2012 | 48 | 0.110 |
Why?
|
| Sex Factors | 5 | 2014 | 859 | 0.100 |
Why?
|
| Patient Satisfaction | 1 | 2012 | 141 | 0.100 |
Why?
|
| Corneal Diseases | 1 | 2010 | 6 | 0.100 |
Why?
|
| Comorbidity | 1 | 2013 | 606 | 0.100 |
Why?
|
| Aberrometry | 1 | 2010 | 1 | 0.100 |
Why?
|
| Acrylic Resins | 1 | 2010 | 7 | 0.100 |
Why?
|
| Fovea Centralis | 1 | 2010 | 3 | 0.090 |
Why?
|
| Menstrual Cycle | 1 | 2010 | 34 | 0.090 |
Why?
|
| Age Factors | 3 | 2019 | 1007 | 0.090 |
Why?
|
| Fuchs' Endothelial Dystrophy | 1 | 2009 | 1 | 0.090 |
Why?
|
| Quality of Life | 1 | 2013 | 459 | 0.090 |
Why?
|
| Iris | 1 | 2009 | 30 | 0.090 |
Why?
|
| Automation | 1 | 2009 | 25 | 0.090 |
Why?
|
| Risk Factors | 3 | 2016 | 3414 | 0.080 |
Why?
|
| Contact Lenses, Hydrophilic | 1 | 2008 | 2 | 0.080 |
Why?
|
| Preoperative Care | 1 | 2007 | 25 | 0.080 |
Why?
|
| Disease Progression | 2 | 2022 | 580 | 0.080 |
Why?
|
| Population Groups | 3 | 2013 | 56 | 0.080 |
Why?
|
| Qualitative Research | 2 | 2019 | 393 | 0.070 |
Why?
|
| Interferometry | 1 | 2005 | 3 | 0.070 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2005 | 24 | 0.070 |
Why?
|
| Corneal Wavefront Aberration | 2 | 2018 | 2 | 0.070 |
Why?
|
| Educational Status | 2 | 2020 | 295 | 0.070 |
Why?
|
| Entrepreneurship | 1 | 2023 | 5 | 0.060 |
Why?
|
| Mydriatics | 1 | 2022 | 5 | 0.060 |
Why?
|
| Ophthalmologic Surgical Procedures | 1 | 2022 | 5 | 0.060 |
Why?
|
| Urban Population | 2 | 2015 | 318 | 0.050 |
Why?
|
| Dilatation, Pathologic | 1 | 2021 | 9 | 0.050 |
Why?
|
| ROC Curve | 1 | 2022 | 138 | 0.050 |
Why?
|
| Health Surveys | 2 | 2015 | 358 | 0.050 |
Why?
|
| Contact Tracing | 1 | 2020 | 17 | 0.050 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2020 | 77 | 0.050 |
Why?
|
| Vaccination | 1 | 2022 | 259 | 0.050 |
Why?
|
| Geography | 1 | 2020 | 86 | 0.050 |
Why?
|
| Lacrimal Apparatus Diseases | 1 | 2019 | 1 | 0.050 |
Why?
|
| Eyelid Diseases | 1 | 2019 | 4 | 0.050 |
Why?
|
| Communicable Disease Control | 1 | 2020 | 31 | 0.050 |
Why?
|
| Income | 1 | 2020 | 135 | 0.040 |
Why?
|
| Hospitalization | 1 | 2022 | 370 | 0.040 |
Why?
|
| Linear Models | 2 | 2009 | 253 | 0.040 |
Why?
|
| Equipment Design | 1 | 2017 | 127 | 0.040 |
Why?
|
| Models, Biological | 1 | 2020 | 642 | 0.040 |
Why?
|
| Esotropia | 1 | 2016 | 4 | 0.040 |
Why?
|
| Needs Assessment | 1 | 2017 | 159 | 0.040 |
Why?
|
| Vision Tests | 1 | 2015 | 4 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2017 | 186 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 570 | 0.030 |
Why?
|
| Intraoperative Period | 1 | 2014 | 3 | 0.030 |
Why?
|
| Biometry | 1 | 2014 | 13 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 555 | 0.030 |
Why?
|
| Refractive Surgical Procedures | 1 | 2014 | 1 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2014 | 8 | 0.030 |
Why?
|
| Cell Count | 1 | 2014 | 129 | 0.030 |
Why?
|
| Rose Bengal | 1 | 2013 | 3 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2014 | 210 | 0.030 |
Why?
|
| Fluorescein | 1 | 2013 | 15 | 0.030 |
Why?
|
| Dark Adaptation | 1 | 2013 | 15 | 0.030 |
Why?
|
| Rural Population | 1 | 2015 | 253 | 0.030 |
Why?
|
| Staining and Labeling | 1 | 2013 | 100 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 841 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 2013 | 173 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 790 | 0.020 |
Why?
|
| Reflex, Pupillary | 1 | 2010 | 3 | 0.020 |
Why?
|
| Tomography, Optical Coherence | 1 | 2010 | 42 | 0.020 |
Why?
|
| Anisocoria | 1 | 2009 | 1 | 0.020 |
Why?
|
| Eye Color | 1 | 2009 | 3 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2009 | 151 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2009 | 111 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2013 | 775 | 0.020 |
Why?
|